Presentation is loading. Please wait.

Presentation is loading. Please wait.

Nicola A. Hanania, MB BS, MS, Bradley E. Chipps, MD, Noelle M

Similar presentations


Presentation on theme: "Nicola A. Hanania, MB BS, MS, Bradley E. Chipps, MD, Noelle M"— Presentation transcript:

1 Omalizumab effectiveness in asthma-COPD overlap: Post hoc analysis of PROSPERO 
Nicola A. Hanania, MB BS, MS, Bradley E. Chipps, MD, Noelle M. Griffin, PhD, Bongin Yoo, PhD, Ahmar Iqbal, MB BS, MBA, Thomas B. Casale, MD  Journal of Allergy and Clinical Immunology  Volume 143, Issue 4, Pages e2 (April 2019) DOI: /j.jaci Copyright © 2018 The Authors Terms and Conditions

2 Fig 1 A, Mean exacerbation at baseline and week 48. B, Mean change (gray bar) in ACT score from baseline (white bar) at week 48 of omalizumab treatment in ACO and asthma cohorts. Journal of Allergy and Clinical Immunology  , e2DOI: ( /j.jaci ) Copyright © 2018 The Authors Terms and Conditions

3 Fig E1 Patient population identification. FVC, Forced vital capacity.
Journal of Allergy and Clinical Immunology  , e2DOI: ( /j.jaci ) Copyright © 2018 The Authors Terms and Conditions

4 Fig E2 Mean (95% CI) change from baseline in postbronchodilator FEV1 after 12 months of omalizumab in the ACO and non-ACO cohorts. Journal of Allergy and Clinical Immunology  , e2DOI: ( /j.jaci ) Copyright © 2018 The Authors Terms and Conditions


Download ppt "Nicola A. Hanania, MB BS, MS, Bradley E. Chipps, MD, Noelle M"

Similar presentations


Ads by Google